Quality of Life After Cardiac Surgery
Key facts
- Who runs it
- Papworth Hospital NHS Foundation Trust
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 2,925 people enrolled
- Started
- 19 Jul 2019
- Ended
- 21 May 2024
- Type of study
- Observational
- Treatments tested
- Cardiac Surgery
- Record updated
- 3 December 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- EuroSCORE II ≥ 3% or EuroSCORE logistic of ≥ 6%
- Patients undergoing routine/ urgent cardiac surgery
- Patients must have the ability to provide informed consent
Who cannot take part
- Patients undergoing salvage or emergency operations
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
During the last twenty years heart surgery has become safer and the number of patients having heart surgery has increased with more frail patients being offered increasingly complex surgery. Heart operations often improve survival and quality of life (QoL), but that is not true for all patients. Regarding survival, clinicians can measure the risk to life from having a heart operation and the risk to life from not quite precisely, but clinicians have little idea about the impact of heart operations on QoL, which is the outcome that patients care about most. Clinicians are unable to provide patients with robust information on how an operation will affect their QoL. This study will provide this information by analysing the data from patient questionnaires immediately before and after the procedure and monthly thereafter for 12 months.
Treatments tested
- Cardiac Surgery
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 3 December 2024